Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Methylaminoantipyrine
2. Monomethylaminoantipyrine
3. Noramidopyrine Mesylate, Sodium Salt
4. Noraminopyrine
1. 519-98-2
2. Noraminopyrine
3. 4-methylaminophenazone
4. 4-methylamino Antipyrine
5. 4-(methylamino)antipyrine
6. 1,5-dimethyl-4-(methylamino)-2-phenyl-1,2-dihydro-3h-pyrazol-3-one
7. 4-monomethylaminoantipyrine
8. 4-methylaminoantipyrine
9. Methylaminoantipyrine
10. 4-monomethylaminophenazone
11. N-methylaminophenazone
12. 1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-3h-pyrazol-3-one
13. Monomethylaminoantipyrine
14. Methylaminophenazone
15. N-methylaminoantipyrine
16. 1,5-dimethyl-4-(methylamino)-2-phenylpyrazol-3-one
17. 3h-pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-
18. Antipyrine, 4-(methylamino)-
19. N.a.p.
20. N-methyl-4-aminophenazone
21. Ner31de951
22. Chembl1164701
23. Chebi:73261
24. Einecs 208-281-3
25. N-methyl-4-aminoantipyrine
26. Brn 0195234
27. Unii-ner31de951
28. 4-(n-methyl)-aminoantipyrine
29. N-desmethylaminopyrine
30. Chemdiv2_002661
31. 4-(methylamino)-antipyrine
32. Oprea1_672076
33. Schembl537958
34. 4-methylamino-antipyrine
35. Noramidopyrine [who-dd]
36. Dtxsid80199865
37. Hms1376i21
38. Zinc121456
39. Albb-010210
40. Bdbm50360021
41. Stk735134
42. Akos003342430
43. Fs-5885
44. Hy-135731
45. Cs-0113885
46. Ft-0648610
47. C15913
48. J-503822
49. 4-(methylamino)antipyrine 100 Microg/ml In Methanol
50. Q27140411
51. 4-(methylamino)antipyrine 100 Microg/ml In Acetonitrile
52. 2,3-dimethyl-4-monomethylamino-1-phenyl-3-pyrazolin5-one
53. B0337-466650
54. Metamizole Sodium Monohydrate Impurity C [ep Impurity]
55. 1,5-dimethyl-4-(methylamino)-2-phenyl-1,2-dihydro-3h-pyrazol-3-one #
56. 1,5-dimethyl-4-methylamino-2-phenyl-1,2-dihydro-3h-pyrazol-3-one
57. 3h-pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-4-(methylamino)-2-phenyl-, Hydrochloride
Molecular Weight | 217.27 g/mol |
---|---|
Molecular Formula | C12H15N3O |
XLogP3 | 0.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 217.121512110 g/mol |
Monoisotopic Mass | 217.121512110 g/mol |
Topological Polar Surface Area | 35.6 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 318 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ANALYTICAL
ABOUT THIS PAGE
A Noramidopyrine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Noramidopyrine, including repackagers and relabelers. The FDA regulates Noramidopyrine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Noramidopyrine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Noramidopyrine supplier is an individual or a company that provides Noramidopyrine active pharmaceutical ingredient (API) or Noramidopyrine finished formulations upon request. The Noramidopyrine suppliers may include Noramidopyrine API manufacturers, exporters, distributors and traders.
Noramidopyrine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Noramidopyrine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Noramidopyrine GMP manufacturer or Noramidopyrine GMP API supplier for your needs.
A Noramidopyrine CoA (Certificate of Analysis) is a formal document that attests to Noramidopyrine's compliance with Noramidopyrine specifications and serves as a tool for batch-level quality control.
Noramidopyrine CoA mostly includes findings from lab analyses of a specific batch. For each Noramidopyrine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Noramidopyrine may be tested according to a variety of international standards, such as European Pharmacopoeia (Noramidopyrine EP), Noramidopyrine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Noramidopyrine USP).
LOOKING FOR A SUPPLIER?